ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1354

The Impact of Pregnancy Intention on Depression and Quality of Life in Women with Lupus

Ceshae Harding1, Amanda Eudy2, Catherine Sims1, Cuoghi Edens3, Mehret Birru Talabi4, Rosalind Ramsey-Goldman5, Laura Neil1 and Megan Clowse6, 1Duke University, Durham, NC, 2Duke University, Raleigh, NC, 3University of Chicago, Chicago, IL, 4University of Pittsburgh, Pittsburgh, PA, 5Northwestern University, Chicago, IL, 6Duke University, Chapel Hill, NC

Meeting: ACR Convergence 2023

Keywords: mental health, pregnancy, quality of life, Systemic lupus erythematosus (SLE), Women's health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1345–1364) Reproductive Issues in Rheumatic Disorders Poster II

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Mental health conditions are the leading cause of maternal mortality across most of the United States. Among individuals with SLE, pregnancy intention has been noted as a risk factor for adverse pregnancy outcomes and infant complications. However, the impact of pregnancy intention on maternal mental health and quality of life in this population is poorly understood.

Methods: We conducted a prospective cohort study using data from a university-based pregnancy registry that enrolls pregnant women with rheumatic disease. Patient reported outcomes including the London Measure of Unplanned Pregnancy (LMUP) and Edinburgh Postnatal Depression Scale (EPDS) were collected at first rheumatology visit of pregnancy. The EPDS is validated in pregnancy. Data for patient measures and physician assessed SLE activity were obtained at each subsequent visit. Pregnancy intention was stratified into two categories: (1) Planned versus unplanned based on LMUP≥10 and (2) Medically optimized versus not optimized. Medically optimized for pregnancy was defined as < 1g of proteinuria, no rheumatic teratogens at conception, and continuing pregnancy compatible SLE medications after conception. We conducted primary and secondary analyses using Fisher’s exact test to estimate the association of pregnancy intention with maternal depression, maternal mental health/quality of life, and maternal SLE activity. Multivariable logistic regression models were used to estimate the association of pregnancy intention with each outcome of interest.

Results:
Depression: Individuals with unplanned pregnancy were 2-3 times as likely to have maternal depression as those with planned pregnancy. On the other hand, individuals who were not medically optimized for pregnancy did not have a significant increase in depression (Table 1).

Patient-reported SLE activity: Higher patient-reported lupus activity was seen in unplanned pregnancy than in planned pregnancy, with three-times as many reporting a moderate or severe flare. However, patient-reported lupus activity was not associated with whether or not pregnancy was medically optimized (Table 2).

Physician-reported SLE activity: When adjusted for marital status, household income, and Medicaid/Medicare insurance, unplanned pregnancies did not have higher SLE activity, despite higher patient-reported symptoms (Table 3).On the other hand, pregnancies that were not medically optimized had significantly higher rates of active SLE, SLEPDAI, and active nephritis, even though the women did not report higher SLE activity.

Conclusion: Early in pregnancy, maternal depression and patient-reported SLE symptoms were associated with unplanned pregnancy, but not whether SLE activity or medications were optimized in pregnancy. On the other hand, physician-reported SLE activity, which is an important predictor of pregnancy outcomes, was not increased in unplanned pregnancies, but was higher in pregnancies not medically optimized. These results suggest that addressing unplanned pregnancy may improve maternal mental health, and increasing medical optimization prior to conception may have more impact on pregnancy outcomes.

Supporting image 1

Table 1. Association between pregnancy intention and maternal depression

Supporting image 2

Table 2. Association between pregnancy intention and patient-reported lupus activity*

Supporting image 3

Table 3. Association between pregnancy intention and provider-reported disease activity*


Disclosures: C. Harding: None; A. Eudy: Amgen, 2, Exagen, 5, GlaxoSmithKlein(GSK), 5, Immunovant, 5, Pfizer, 5; C. Sims: None; C. Edens: None; M. Birru Talabi: None; R. Ramsey-Goldman: Ampel Solutions, 2, Calabetta, 2, Exagen, 2, Immunocor, 6; L. Neil: None; M. Clowse: Exagen, 5, GlaxoSmithKlein(GSK), 2, 5, Immunovant, 5, UCB, 2, 5.

To cite this abstract in AMA style:

Harding C, Eudy A, Sims C, Edens C, Birru Talabi M, Ramsey-Goldman R, Neil L, Clowse M. The Impact of Pregnancy Intention on Depression and Quality of Life in Women with Lupus [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/the-impact-of-pregnancy-intention-on-depression-and-quality-of-life-in-women-with-lupus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-impact-of-pregnancy-intention-on-depression-and-quality-of-life-in-women-with-lupus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology